Tags

Type your tag names separated by a space and hit enter

Combined corticosteroid and long-acting beta 2 -agonist in one inhaler versus placebo for chronic obstructive pulmonary disease: Cochrane systematic review

Combined corticosteroid and long-acting beta 2 -agonist in one inhaler versus placebo for chronic obstructive pulmonary disease: Cochrane systematic review is a topic covered in the Cochrane Abstracts.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central

Citation

"Combined Corticosteroid and Long-acting Beta 2 -agonist in One Inhaler Versus Placebo for Chronic Obstructive Pulmonary Disease: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431942/all/Combined_corticosteroid_and_long_acting_beta_2__agonist_in_one_inhaler_versus_placebo_for_chronic_obstructive_pulmonary_disease:_Cochrane_systematic_review. Accessed 21 July 2019.
Combined corticosteroid and long-acting beta 2 -agonist in one inhaler versus placebo for chronic obstructive pulmonary disease: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431942/all/Combined_corticosteroid_and_long_acting_beta_2__agonist_in_one_inhaler_versus_placebo_for_chronic_obstructive_pulmonary_disease:_Cochrane_systematic_review. Accessed July 21, 2019.
Combined corticosteroid and long-acting beta 2 -agonist in one inhaler versus placebo for chronic obstructive pulmonary disease: Cochrane systematic review. In Cochrane Abstracts. Available from https://evidence.unboundmedicine.com/evidence/view/Cochrane/431942/all/Combined_corticosteroid_and_long_acting_beta_2__agonist_in_one_inhaler_versus_placebo_for_chronic_obstructive_pulmonary_disease:_Cochrane_systematic_review
Combined Corticosteroid and Long-acting Beta 2 -agonist in One Inhaler Versus Placebo for Chronic Obstructive Pulmonary Disease: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2019 July 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431942/all/Combined_corticosteroid_and_long_acting_beta_2__agonist_in_one_inhaler_versus_placebo_for_chronic_obstructive_pulmonary_disease:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Combined corticosteroid and long-acting beta 2 -agonist in one inhaler versus placebo for chronic obstructive pulmonary disease: Cochrane systematic review ID - 431942 BT - Cochrane Abstracts UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431942/all/Combined_corticosteroid_and_long_acting_beta_2__agonist_in_one_inhaler_versus_placebo_for_chronic_obstructive_pulmonary_disease:_Cochrane_systematic_review DB - Evidence Central DP - Unbound Medicine ER -